EXAMINATION OF THE PROTECTIVE EFFECT OF 6-SHOGAOL AGAINST LPS-INDUCED ACUTE LUNG INJURY IN MICE VIA NF-κB ATTENUATION

Authors

  • Jing-Chao Wang 1. Department of Respiratory Medicine, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515; 2. Department of Critical Care, Affiliated Hospital of Inner Mongolia Medical University, Inner Mongolia 010050
  • Li-Hua Zhou Department of Critical Care, Affiliated Hospital of Inner Mongolia Medical University, Inner Mongolia 010050
  • Hai-Jin Zhao Department of Respiratory Medicine, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515
  • Shao-Xi Cai Department of Respiratory Medicine, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515

Abstract

Acute lung injury (ALI), the causative factor for acute respiratory distress syndrome, results in significant morbidity and mortality. Due to a lack of effective therapeutic options for ALI, the development of novel therapies is urgently needed. NF-κB, an inflammatory mediator necessary for the evolution of ALI, could serve as an important target for novel agents to prevent disease progression. The present study was designed to evaluate the protective effect of 6-shogaol against lipopolysaccharide (LPS)-induced ALI in mice, and its mechanism of action. Our results suggest that 6-shogaol significantly attenuates elevated levels of various proinflammatory cytokines, such as tumor necrosis factor alpha (TNFα), IL-1β and IL-6. Moreover, the influx of neutrophils, increased protein concentration and edema were also suppressed in mice pretreated with 6-shogaol. These observations were also confirmed by histopathological examination of lung tissues, which suggests that 6-shogaol significantly improves the pathological condition to normal in a dose-dependent manner. A docking study of 6-shogaol was also performed, with the NF-κB p50 homodimer bound to a κB site, to determine its possible inhibitory effects. Our results show that 6-shogaol was efficiently accommodated in the deep cleft of the active site, lined with residues Tyr57, Val58 and Cys59, Tyr143, Lys145 and Lys146 of Chain B of p50 NF-κB.

 

Key words: acute lung injury; NF-κB; 6-shogaol; cytokines; LPS

 

Received: October 12, 2015; Revised: December 22, 2015; Accepted: January 4, 2015; Published online: May 26, 2016

Downloads

Download data is not yet available.

References

Ware LB, Matthay MA. The acute respiratory distress syndrome. N Engl J Med. 2000;342:1334-49.

Herridge MS, Angus DC. Acute lung injury − affecting many lives. N Engl J Med. 2005;353:1736-8.

Repine JE. Scientific perspectives on adult respiratory distress syndrome. Lancet. 1992;339:466-9.

Wang Z, Jiang W, Zhang Z, Qian M, Du B. Nitidine chloride inhibits LPS induced inflammatory cytokines production via MAPK and NF-kappaB pathway in RAW 264.7 cells. J Ethnopharmacol. 2012;144:145-50.

Sun Q, Chen L, Gao MY, Jiang WW, Shao FX, Li JJ, Wang J, Kou JP, Yu BY. Ruscogenin inhibits lipopolysaccharide-induced acute lung injury in mice: involvement of tissue factor, inducible NO synthase and nuclear factor (NF)-κB. Int Immunopharmacol. 2012;12:88-93.

Gao M, Chen L, Yu H, Sun Q, Kou J, Yu B. Diosgenin down-regulates NF-κB p65/p50 and p38MAPK pathways and attenuates acute lung injury induced by lipopolysaccharide in mice. Int Immunopharmacol. 2013;15(2):240-5.

Lu HJ, Tzeng TF, Liou SS, Chang CJ, Yang C, Wu MC, Liu IM. Ruscogenin ameliorates experimental nonalcoholic steatohepatitis via suppressing lipogenesis and inflammatory pathway. Biomed Res Int. 2014;2014:652680.

Lee KC, Chang HH, Chung YH, Tzung-Yan Lee TY. Andrographolide acts as an anti-inflammatory agent in LPS-stimulated RAW264.7 macrophages by inhibiting STAT3-mediated suppression of the NF-κB pathway. J Ethnopharmacol. 2011;135:678-84.

Lawrence T. The nuclear factor NF-kappaB pathway in inflammation. Cold Spring Harb Perspect Biol. 2009;1:a001651.

Ali BH, Blunden G, Tanira MO, Nemmar A. Some phytochemical, pharmacological and toxicological properties of ginger (Zingiber officinale Roscoe): a review of recent research. Food Chem Toxicol. 2008;46:409-20.

Kundu JK, Na HK, Surh YJ. Ginger-derived phenolic substances with cancer preventive and therapeutic potential. Forum Nutr. 2009;61:182-92.

Jolad SD, Lantz RC, Chen GJ, Bates RB, Timmermann BN. Commercially processed dry ginger (Zingiber officinale): composition and effects on LPS-stimulated PGE2 production. Phytochemistry. 2005;66:1614-35.

Pan MH, Hsieh MC, Kuo JM, Lai CS, Wu H, Sang S, Ho CT. 6-Shogaol induces apoptosis in human colorectal carcinoma cells via ROS production, caspase activation, and GADD 153 expression. Mol Nutr Food Res. 2008;52:527-37.

Giebelen IA, van Westerloo DJ, LaRosa GJ, de Vos AF, van der PollT. Local stimulation of alpha7 cholinergic receptors inhibits LPS-induced TNF-alpha release in the mouse lung. Shock. 2007;28:700-3.

Goodman RB, Pugin J, Lee JS, Matthay MA. Cytokine-mediated inflammation in acute lung injury. Cytokine Growth Factor Rev. 2003;14:523-35.

Minamino T, Komuro I. Regeneration of the endothelium as a novel therapeutic strategy for acute lung injury. J Clin Invest. 2006;116:2316-9.

Perkins ND. Integrating cell-signalling pathways with NF-kappa-B and IKK function. Nat Rev Mol Cell Biol. 2007;8:49-62.

Downloads

Published

2016-09-05

How to Cite

1.
Wang J-C, Zhou L-H, Zhao H-J, Cai S-X. EXAMINATION OF THE PROTECTIVE EFFECT OF 6-SHOGAOL AGAINST LPS-INDUCED ACUTE LUNG INJURY IN MICE VIA NF-κB ATTENUATION. Arch Biol Sci [Internet]. 2016Sep.5 [cited 2024Dec.22];68(3):633-9. Available from: https://serbiosoc.org.rs/arch/index.php/abs/article/view/982

Issue

Vol. 68 No. 3 (2016)

Section

Articles

License

Authors grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution 4.0 International License that allows others to share the work with an acknowledgment of the work’s authorship and initial publication in this journal.